Dr. Santu Bandyopadhyay

Chief Scientist
Ph.D, Calcutta University, 1982
Contact - santu2@iicb.res.in / drsantub@yahoo.com

1. Mr. Nabendu Biswas, SRF-CSIR

1. Mr. Anirban Manna, Sr.Technician (1)

1. Surjendu Bikash Debnath, (Job Contract)
2. Dr. Arup Ratan Biswas(Job Contract)

List of important Publications:

1. Wagh V., Chile S., Monahar S., Pal BC., Bandyopadhyay S., Sharma S. and Joshi K. NPB001-05 inhibits Bcr-Abl kinase leading to apoptosis of imatinib-resistant cells. Front Biosci (Elite Ed). 2011, 3: 1273-88.
2. Manna PP., Chakrabarti G. and Bandyopadhyay S. Innate immune defense in visceral leishmaniasis: Cytokine mediated protective role by allogeneic effector cell. Vaccine. 2010, 28: 803-810. Vaccine, 2010.
3. Rakshit S., Mandal L., Pal BC., Bagchi J., Biswas N., Chaudhuri J., Chowdhury AA., Manna A., Chaudhuri U., Konar A., Mukherjee T., Jaisankar P. and Bandyopadhyay S. Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl(+) CML cells. Biochemical Pharmacology. 2010, 80: 1662-1675.
4. Rakshit S., Bagchi J., Mandal L., Paul K., Ganguly D., Bhattacharjee S., Ghosh M., Biswas N., Chaudhuri U. and Bandyopadhyay S. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide. Apoptosis. 2009, 14: 298-308.
5. Ghosh M., Mandal L., Maitra S., Rakshit S., Paul K., Bagchi J., Ganguly D., Pal C. and Bandyopadhyay S. Leishmania donovani infection of human myeloid dendritic cells leads to Th1 response in CD4+ T cells of normal donors and Kala-azar patients. J Infect Dis. 2006, 194: 294-301.
6. Bandyopadhyay G., Biswas T., Roy KC., Mandal S., Mandal C., Pal BC., Bhattacharya S., Rakshit S., Bhattacharya DK., Chaudhuri U., Konar A. and Bandyopadhyay S. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood. 2004, 104 (8): 2514-2522.
7. Roy KC., Bandyopadhyay G., Rakshit S., Ray M. and Bandyopadhyay S. IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1a(dim), CD83(+) myeloid dendritic cell subset. J Cell Sci. 2004, 117: 3435-3445.
8. Ghosh, M., Pal, C., Ray, M., Maitra, S., Mandal, L. and Bandyopadhyay, S. Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis. J. Immunol. 2003, 170: 5625-5629.
9. Pal, C., Raha, M., Basu, A., Roy, KC., Gupta, A., Ghosh, M., Sahu NP., Banerjee, S., Mandal, NB. and Bandyopadhyay, S. Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters. Antimicrobial Agents And Chemotherapy. 2002, 46: 259-261.
10. Bandyopadhyay, S., Perussia, B., Trinchieri, G., Miller, D.S. and Starr, S.E.  Requirement of HLA-DR accessory cells in natural killing of cytomegalovirus infected fibroblasts. J. Exp. Med. 1986, 164: 180-185.

Detail list of Publications upto December'2010 ==>> Click here